PI

Both improvement of glycaemic control and reduction
of cardiovascular morbidity and mortality are an integral
part of the treatment of type 2 diabetes.1 Use Forxiga in your adult patients with insufficiently
controlled type 2 diabetes1

With Heart Failure or,2,3

With risk factors for Heart Failure3

Both improvement of glycaemic control and reduction of cardiovascular morbidity and mortality are an integral part of the treatment of type 2 diabetes.1Use Forxiga in your adult patients with insufficientlycontrolled type 2 diabetes1

With Heart Failure or,2,3

With risk factors for Heart Failure3

Heart failure is an under-recognised complication of T2D

Use of Forxiga in T2D is supported by data in
DECLARE TIMI-58 and DAPA HF2,3

Data from the Landmark DAPA-HF Trial***

 

 

In both study arms, treatment was on top of standard of care.

Forxiga also lowers HbA1c with additional benefits of weight
and blood pressure reduction vs Placebo11#

HbA1c reductions of -0.84% from baseline at 24 weeks11

-2.9 kg weight loss from baseline at 24 weeks11#

-5.1 mmHg systolic blood pressure reduction from baseline at 24 weeks11#

Safety and tolerability

 

 

When prescribing in patients with co-morbid symptomatic HFrEF and insufficiently controlled T2D1

Simple once-daily dosing§§, no dose adjustment required based on renal function.

 

 

§§ No dose adjustment is necessary for patients with mild or moderate hepatic impairment. In patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, the dose may be increased to 10 mg1

Have a question about Forxiga in T2D?

We’re here to help.